{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:58:57Z","timestamp":1782377937049,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10787-025-01965-x","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T06:59:26Z","timestamp":1758783566000},"page":"6017-6039","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating the preclinical efficacy of naringenin in rheumatoid arthritis: a meta-analysis of in vivo studies"],"prefix":"10.1007","volume":"33","author":[{"given":"Muhammad Muzammil","family":"Nazir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asad","family":"Sajid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7026-670X","authenticated-orcid":false,"given":"Asma","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"issue":"9","key":"1965_CR1","first-page":"265","volume":"30","author":"N Agarwal","year":"2020","unstructured":"Agarwal N, Kamaraj A, McDonnell S, Khan W (2020) Perioperative management of patients with rheumatoid arthritis undergoing orthopaedic surgery. J Perioper Pract 30(9):265\u2013270","journal-title":"J Perioper Pract"},{"issue":"38","key":"1965_CR2","doi-asserted-by":"publisher","first-page":"34476","DOI":"10.1021\/acsomega.2c04148","volume":"7","author":"A Ahmad","year":"2022","unstructured":"Ahmad A, Prakash R, Khan MS, Altwaijry N, Asghar MN, Raza SS, Khan R (2022) Enhanced antioxidant effects of naringenin nanoparticles synthesized using the high-energy ball milling method. ACS Omega 7(38):34476\u201334484","journal-title":"ACS Omega"},{"key":"1965_CR3","first-page":"5393","volume":"8","author":"OM Ahmed","year":"2024","unstructured":"Ahmed OM, Khalifa MM, Atia T, Ahmed RR, Abdel-Hafez DA, Rahman FEZSA, Damanhory AA, Metawee ME, Alqassimi Elagali AM, S (2024) The anti-arthritic role of naringenin through modulating different t helper cells\u2019 cytokines, inflammatory mediators, oxidative stress and anti-oxidant defense system. J Biol Regul Homeost Agents 8:5393\u2013405","journal-title":"J Biol Regul Homeost Agents"},{"key":"1965_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.672054","volume":"12","author":"Y Aihaiti","year":"2021","unstructured":"Aihaiti Y, Song Cai Y, Tuerhong X, Ni Yang Y, Ma Y, Shi Zheng H, Xu K, Xu P (2021) Therapeutic effects of naringin in rheumatoid arthritis: network pharmacology and experimental validation. Front Pharmacol 12:672054","journal-title":"Front Pharmacol"},{"issue":"3","key":"1965_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3923\/ijp.2023.305.312","volume":"19","author":"SM Alqahtani","year":"2023","unstructured":"Alqahtani SM, Khired ZA, Dawood AF, Alshahrani MY, Alzamil NM, Al-Ani BS, Al-Hashem FH (2023) Synovial knee joint in rheumatoid arthritis treated with TDZD-8: an association between synovial fibrosis and the TNF-\u03b1\/VEGF\/\u03b1-SMA axis. Int J Pharmacol 19(3):305\u2013312","journal-title":"Int J Pharmacol"},{"key":"1965_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.155945","author":"MZA Begh","year":"2025","unstructured":"Begh MZA, Zehravi M, Reza F, Sweilam SH, Shanmugarajan TS, Arjun UVNV, Devi K, Ethiraj S, Kumar VS, Thilagam E (2025) Therapeutic potential of phytocompounds in rheumatoid arthritis: molecular insights and clinical applications. Pathol-Res Pract. https:\/\/doi.org\/10.1016\/j.prp.2025.155945","journal-title":"Pathol-Res Pract"},{"key":"1965_CR7","doi-asserted-by":"publisher","unstructured":"Brown P, Pratt AG, Hyrich KL (2024) Therapeutic advances in rheumatoid arthritis. BMJ 384:e070856. https:\/\/doi.org\/10.1136\/bmj-2022-070856","DOI":"10.1136\/bmj-2022-070856"},{"key":"1965_CR8","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s10787-018-00561-6","volume":"27","author":"AJ Bussmann","year":"2019","unstructured":"Bussmann AJ, Borghi SM, Zaninelli TH, Dos Santos TS, Guazelli CF, Fattori V, Domiciano TP, Pinho-Ribeiro FA, Ruiz-Miyazawa KW, Casella AM (2019) The citrus flavanone naringenin attenuates zymosan-induced mouse joint inflammation: induction of Nrf2 expression in recruited CD45+ hematopoietic cells. Inflammopharmacology 27:1229\u20131242","journal-title":"Inflammopharmacology"},{"key":"1965_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114990","volume":"164","author":"J Cai","year":"2023","unstructured":"Cai J, Wen H, Zhou H, Zhang D, Lan D, Liu S, Li C, Dai X, Song T, Wang X (2023) Naringenin: a flavanone with anti-inflammatory and anti-infective properties. Biomed Pharmacother 164:114990","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1965_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101740","volume":"36","author":"DI Daikh","year":"2022","unstructured":"Daikh DI (2022) Rheumatoid arthritis: evolving recognition of a common disease. Best Pract Res Clin Rheumatol 36(1):101740","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"1965_CR11","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3390\/antibiotics11111628","volume":"11","author":"A Duda-Madej","year":"2022","unstructured":"Duda-Madej A, Stecko J, Sobieraj J, Szyma\u0144ska N, Koz\u0142owska J (2022) Naringenin and its derivatives\u2014health-promoting phytobiotic against resistant bacteria and fungi in humans. Antibiotics 11(11):1628","journal-title":"Antibiotics"},{"key":"1965_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.pharep.2017.03.020","volume":"69","author":"R Fan","year":"2017","unstructured":"Fan R, Pan T, Zhu A-L, Zhang M-H (2017) Anti-inflammatory and anti-arthritic properties of naringenin via attenuation of NF-\u03baB and activation of the heme oxygenase (HO)-1\/related factor 2 pathway. Pharmacol Rep 69:1021\u20131029","journal-title":"Pharmacol Rep"},{"issue":"10","key":"1965_CR13","first-page":"591","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh A, Gilbert B, Hodkinson B, Bae S-C, Thomas R, Deane KD, Alpizar-Rodriguez D, Lauper K (2022) Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol 18(10):591\u2013602","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1965_CR14","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1021\/acs.jafc.9b05218","volume":"68","author":"S Gao","year":"2019","unstructured":"Gao S, Lyu Y, Zeng W, Du G, Zhou J, Chen J (2019) Efficient biosynthesis of (2 S)-naringenin from p-coumaric acid in Saccharomyces cerevisiae. J Agric Food Chem 68(4):1015\u20131021","journal-title":"J Agric Food Chem"},{"issue":"4","key":"1965_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3390\/nutraceuticals4040035","volume":"4","author":"T Gonz\u00e1lez Heredia","year":"2024","unstructured":"Gonz\u00e1lez Heredia T, Hern\u00e1ndez Corona DM, M\u00e9ndez del Villar M, Guzm\u00e1n Ornelas MO, Corona Meraz FI, Ch\u00e1vez Tostado M, Diosdado Pardo GE, P\u00e9rez Padilla AJ, P\u00e9rez Villalobos FB, Monta\u00f1o Vargas PY (2024) Adjunctive therapies in rheumatoid arthritis. Nutraceuticals 4(4):643\u2013657","journal-title":"Nutraceuticals"},{"issue":"1","key":"1965_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res 6(1):15","journal-title":"Bone Res"},{"key":"1965_CR17","unstructured":"Hajizadeh A, SM AF, Tehrani A, Azizi S, SR BH (2021) Effects of naringenin on experimentally induced rheumatoid arthritis in wistar rats. Arch Razi Inst 76(4):903"},{"issue":"5","key":"1965_CR18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/ard-2023-225237","volume":"83","author":"Y He","year":"2024","unstructured":"He Y, Aoun M, Xu Z, Holmdahl R (2024) Shift in perspective: autoimmunity protecting against rheumatoid arthritis. Ann Rheum Dis 83(5):550\u2013555","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1965_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12902-025-01915-2","volume":"25","author":"H Hu","year":"2025","unstructured":"Hu H, Zhou C, Jiang B, Wu S, Cai T, Yu J, Zhu L, Zhou B (2025) Expression and clinical significance of LncRNA Kcnq1ot1 in type 2 diabetes mellitus patients with osteoarthritis. BMC Endocr Disord 25(1):131","journal-title":"BMC Endocr Disord"},{"key":"1965_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-0172(79)80005-0","author":"ER Hurd","year":"1979","unstructured":"Hurd ER (1979) Extraarticular manifestations of rheumatoid arthritis. Semin Arthritis Rheum. https:\/\/doi.org\/10.1016\/s0049-0172(79)80005-0","journal-title":"Semin Arthritis Rheum"},{"key":"1965_CR21","doi-asserted-by":"publisher","DOI":"10.54393\/pbmj.v7i08.1099","author":"T Iqbal","year":"2024","unstructured":"Iqbal T, Sidra A, Iman B, Muhammad AN, Qaiser A, Muhammad RS, Shahbaz H,  Ume S (2024) Hesperetin: A Potent Phytochemical Constituent for the Treatment of Rheumatoid Arthritis: Hesperetin for the Treatment of Rheumatoid Arthritis. Pak Biomed J 02\u201310. https:\/\/doi.org\/10.54393\/pbmj.v7i08.1099","journal-title":"Pakistan BioMedical Journal"},{"issue":"1","key":"1965_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13075-022-02975-8","volume":"24","author":"Y-P Jiang","year":"2022","unstructured":"Jiang Y-P, Wang S, Lai W-D, Wu X-Q, Jin Y, Xu Z-H, Moutal A, Khanna R, Park KD, Shan Z-M (2022a) Neuronal CRMP2 phosphorylation inhibition by the flavonoid, naringenin, contributes to the reversal of spinal sensitization and arthritic pain improvement. Arthritis Res Ther 24(1):277","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1965_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/ijms24010279","volume":"24","author":"Y-P Jiang","year":"2022","unstructured":"Jiang Y-P, Wen J-J, Zhao X-X, Gao Y-C, Ma X, Song S-Y, Jin Y, Shao T-J, Yu J, Wen C-P (2022b) The flavonoid naringenin alleviates collagen-induced arthritis through curbing the migration and polarization of CD4+ T lymphocyte driven by regulating mitochondrial fission. Int J Mol Sci 24(1):279","journal-title":"Int J Mol Sci"},{"key":"1965_CR24","doi-asserted-by":"publisher","unstructured":"Jiteshbhai AM, Vadgama NS, Prajapati AP, Narkhede SB, Luhar S, Vrushant O. A Review on Nutritional Management in Rheumatoid Arthritis. https:\/\/doi.org\/10.36713\/epra15261","DOI":"10.36713\/epra15261"},{"issue":"2","key":"1965_CR25","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/fsn3.2063","volume":"9","author":"H Kataoka","year":"2021","unstructured":"Kataoka H, Saeki A, Hasebe A, Shibata Ki, Into T (2021) Naringenin suppresses toll-like receptor 2-mediated inflammatory responses through inhibition of receptor clustering on lipid rafts. Food Sci Nutr 9(2):963\u2013972","journal-title":"Food Sci Nutr"},{"key":"1965_CR26","doi-asserted-by":"publisher","first-page":"1213602","DOI":"10.3389\/fphar.2023.1213602","volume":"14","author":"J Lang","year":"2023","unstructured":"Lang J, Li L, Quan Y, Tan R, Zhao J, Li M, Zeng J, Chen S, Wang T, Li Y (2023) LC-MS-based metabolomics reveals the mechanism of anti-gouty arthritis effect of Wuwei Shexiang pill. Front Pharmacol 14:1213602","journal-title":"Front Pharmacol"},{"issue":"1","key":"1965_CR27","doi-asserted-by":"publisher","first-page":"15125","DOI":"10.1038\/s41598-023-42207-w","volume":"13","author":"T-H Lee","year":"2023","unstructured":"Lee T-H, Wu M-C, Lee M-H, Liao P-L, Lin C-C, Wei JC-C (2023) Influence of helicobacter pylori infection on risk of rheumatoid arthritis: a nationwide population-based study. Sci Rep 13(1):15125","journal-title":"Sci Rep"},{"issue":"12","key":"1965_CR28","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.jnutbio.2015.07.016","volume":"26","author":"Y-R Li","year":"2015","unstructured":"Li Y-R, Chen D-Y, Chu C-L, Li S, Chen Y-K, Wu C-L, Lin C-C (2015) Naringenin inhibits dendritic cell maturation and has therapeutic effects in a murine model of collagen-induced arthritis. J Nutr Biochem 26(12):1467\u20131478","journal-title":"J Nutr Biochem"},{"issue":"21","key":"1965_CR29","doi-asserted-by":"publisher","first-page":"11985","DOI":"10.3390\/ijms222111985","volume":"22","author":"W-S Li","year":"2021","unstructured":"Li W-S, Lin S-C, Chu C-H, Chang Y-K, Zhang X, Lin C-C, Tung Y-T (2021) The gastroprotective effect of naringenin against ethanol-induced gastric ulcers in mice through inhibiting oxidative and inflammatory responses. Int J Mol Sci 22(21):11985","journal-title":"Int J Mol Sci"},{"issue":"32","key":"1965_CR30","doi-asserted-by":"publisher","first-page":"11026","DOI":"10.1080\/10408398.2022.2092054","volume":"63","author":"Z Liu","year":"2023","unstructured":"Liu Z, Niu X, Wang J (2023) Naringenin as a natural immunomodulator against T cell-mediated autoimmune diseases: literature review and network-based pharmacology study. Crit Rev Food Sci Nutr 63(32):11026\u201311043","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1965_CR31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00011-018-1195-y","volume":"67","author":"MF Manchope","year":"2018","unstructured":"Manchope MF, Artero NA, Fattori V, Mizokami SS, Pitol DL, Issa JP, Fukada SY, Cunha TM, Alves-Filho JC, Cunha FQ (2018) Naringenin mitigates titanium dioxide (TiO 2)-induced chronic arthritis in mice: role of oxidative stress, cytokines, and NF\u03bab. Inflamm Res 67:997\u20131012","journal-title":"Inflamm Res"},{"key":"1965_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102854","volume":"66","author":"A Munir","year":"2021","unstructured":"Munir A, Muhammad F, Zaheer Y, Ali MA, Iqbal M, Rehman M, Munir MU, Akhtar B, Webster TJ, Sharif A (2021) Synthesis of naringenin loaded lipid based nanocarriers and their in-vivo therapeutic potential in a rheumatoid arthritis model. J Drug Deliv Sci Technol 66:102854","journal-title":"J Drug Deliv Sci Technol"},{"key":"1965_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01612-x","author":"MM Nazir","year":"2024","unstructured":"Nazir MM, Farzeen I, Fasial S, Ashraf A (2024) Berberine in rheumatoid arthritis: a comprehensive review and meta-analysis of its anti-inflammatory and immunomodulatory mechanisms in animal models. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-024-01612-x","journal-title":"Inflammopharmacology"},{"key":"1965_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149613","volume":"704","author":"J Pan","year":"2024","unstructured":"Pan J, Meng L, Li R, Wang Z, Yuan W, Li Y, Chen L, Shen Q, Liu W, Zhu L (2024) Naringenin protects against septic cardiomyopathy in mice by targeting HIF-1\u03b1. Biochem Biophys Res Commun 704:149613","journal-title":"Biochem Biophys Res Commun"},{"key":"1965_CR35","first-page":"e934475","volume":"27","author":"DV Parums","year":"2021","unstructured":"Parums DV (2021) Review articles, systematic reviews, meta-analysis, and the updated preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 guidelines. Med Sci Monit Int Med J Exp Clin Res 27:e934475\u2013e934471","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"1965_CR36","unstructured":"PRISMA P (2020) Preferred reporting items for systematic reviews and meta-analyses (PRISMA), 2020. In"},{"issue":"3","key":"1965_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2174\/1386207326666230914103714","volume":"27","author":"N Rana","year":"2024","unstructured":"Rana N, Gupta P, Singh H, Nagarajan K (2024) Role of bioactive compounds, novel drug delivery systems, and polyherbal formulations in the management of rheumatoid arthritis. Combin Chem High Throughput Screen 27(3):353\u2013385","journal-title":"Combin Chem High Throughput Screen"},{"issue":"1","key":"1965_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ph12010011","volume":"12","author":"B Salehi","year":"2019","unstructured":"Salehi B, Fokou PVT, Sharifi-Rad M, Zucca P, Pezzani R, Martins N, Sharifi-Rad J (2019) The therapeutic potential of naringenin: a review of clinical trials. Pharmaceuticals 12(1):11","journal-title":"Pharmaceuticals"},{"issue":"27","key":"1965_CR39","doi-asserted-by":"publisher","first-page":"8868","DOI":"10.1080\/10408398.2022.2056726","volume":"63","author":"S Singh","year":"2023","unstructured":"Singh S, Sharma A, Monga V, Bhatia R (2023) Compendium of naringenin: potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile. Crit Rev Food Sci Nutr 63(27):8868\u20138899","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"1965_CR40","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC201901010","volume":"170","author":"JA Sparks","year":"2019","unstructured":"Sparks JA (2019) Rheumatoid arthritis. Annal Intern Med Clin 170(1):ITC1-ITC16e16","journal-title":"Annal Intern Med Clin"},{"key":"1965_CR41","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1136\/annrheumdis-2022-eular.3491","volume":"81","author":"H Wang","year":"2022","unstructured":"Wang H, Zhang Y (2022) POS0433 potential therapeutic effects of naringenin on RA through suppressing P2X7R\/NLRP3 mediated pyroptosis by targeting ESR. Ann Rheum Dis 81:471","journal-title":"Ann Rheum Dis"},{"key":"1965_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156171","volume":"135","author":"W Wang","year":"2024","unstructured":"Wang W, Zhai S, Yang W, Gao H, Chang N, Zhang M, Hou Y, Bai G (2024a) Acacetin alleviates rheumatoid arthritis by targeting HSP90 ATPase domain to promote COX-2 degradation. Phytomedicine 135:156171","journal-title":"Phytomedicine"},{"key":"1965_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2024.106557","volume":"169","author":"X Wang","year":"2024","unstructured":"Wang X, Zhang X, Liu Z, Zhao N, Li X, Su P, Zheng G, Zhang X, Wang H, Zhang Y (2024b) Naringenin nanoparticles targeting cyclin B1 suppress the progression of rheumatoid arthritis-associated lung cancer by inhibiting fibroblast-to-myofibroblast transition. Int J Biochem Cell Biol 169:106557","journal-title":"Int J Biochem Cell Biol"},{"key":"1965_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2025.110563","author":"J Xu","year":"2025","unstructured":"Xu J, Wang Z, Ren Z, Wan Z, Zhang Y, Li R, Zhu Y (2025) Naringenin inhibits PRV replication by regulating the TLR4\/NF-\u03baB pathway mediated inflammatory response. Vet Microbiol. https:\/\/doi.org\/10.1016\/j.vetmic.2025.110563","journal-title":"Vet Microbiol"},{"key":"1965_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.molimm.2021.07.003","volume":"137","author":"J Yang","year":"2021","unstructured":"Yang J, Liu L, Li M, Huang X, Yang H, Li K (2021) Naringenin inhibits pro-inflammatory cytokine production in macrophages through inducing MT1G to suppress the activation of NF-\u03baB. Mol Immunol 137:155\u2013162","journal-title":"Mol Immunol"},{"issue":"6","key":"1965_CR46","first-page":"816","volume":"16","author":"G Zhang","year":"2021","unstructured":"Zhang G, Sun G, Guan H, Li M, Liu Y, Tian B, He Z, Fu Q (2021) Naringenin nanocrystals for improving anti-rheumatoid arthritis activity. Asian J Pharm Sci 16(6):816\u2013825","journal-title":"Asian J Pharm Sci"},{"issue":"10","key":"1965_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.983","volume":"11","author":"W Zhang","year":"2023","unstructured":"Zhang W, Zhang Y, Zhang J, Deng C, Zhang C (2023) Naringenin ameliorates collagen-induced arthritis through activating AMPK-mediated autophagy in macrophages. Immunity Inflamm Dis 11(10):e983","journal-title":"Immunity Inflamm Dis"},{"issue":"1","key":"1965_CR48","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/s41598-024-52413-9","volume":"14","author":"J Zhou","year":"2024","unstructured":"Zhou J, Li H, Wu B, Zhu L, Huang Q, Guo Z, He Q, Wang L, Peng X, Guo T (2024b) Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer. Sci Rep 14(1):1860","journal-title":"Sci Rep"},{"key":"1965_CR49","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-025-02555-8","author":"L Zhou","year":"2025","unstructured":"Zhou L, Yang T, Zhang S, Liu D, Feng C, Ni J, Shi Q, Liu Y, Meng Y, Zhu Y (2025) Targeting myeloid differentiation protein 2 ameliorates rheumatoid arthritis by inhibiting inflammation and ferroptosis via MAPK and NF-\u03baB signaling pathways. J Mol Med. https:\/\/doi.org\/10.1007\/s00109-025-02555-8","journal-title":"J Mol Med"},{"key":"1965_CR50","doi-asserted-by":"crossref","unstructured":"Zhou C, Kuang M, Tao Y, Wang J, Luo Y, Fu Y, Chen Z, Liu Y, Li Z, Wu W (2024) Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening. Cell Stem Cell 31(9):1359\u20131375 (e1358)","DOI":"10.1016\/j.stem.2024.06.007"},{"key":"1965_CR51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10753-014-0027-7","volume":"38","author":"L Zhu","year":"2015","unstructured":"Zhu L, Wang J, Wei T, Gao J, He H, Chang X, Yan T (2015) Effects of naringenin on inflammation in complete freund\u2019s adjuvant-induced arthritis by regulating Bax\/Bcl-2 balance. Inflammation 38:245\u2013251","journal-title":"Inflammation"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01965-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01965-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01965-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:05:42Z","timestamp":1761332742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01965-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1965"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01965-x","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}